Patients with ET have mutations in the CALR gene that encodes the endoplasmic reticulum and are associated with chaperone calreticulin at a frequency of 20% to 25%. CALR mutations are frequently seen in ET and PMF patients with JAK2 wild and MPL wild type. This evidence concerns the gene JAK2 and essential thrombocythemia.